Myasthenia Gravis (MG)
Definition: Myasthenia Gravis is an autoimmune disease of the neuromuscular junction characterized by fluctuating skeletal muscle weakness and fatigability due to impaired neuromuscular transmission.
Etiology
1.Autoantibodies Against: Acetylcholine receptor (AChR) (most common). Muscle-specific kinase (MuSK). LRP4 (rare)
2.Associated Conditions: Thymic hyperplasia. Thymoma slow-growing tumor that forms on the outside of the thymus gland
Pathogenesis
Autoantibodies destroy or block postsynaptic ACh receptors → ↓ Neuromuscular transmission → Muscle weakness that worsens with activity and improves with rest.
Clinical Features
Hallmark: Fluctuating fatigable weakness
Ocular Symptoms (Most Common Initial Presentation): Ptosis. Diplopia
Bulbar Symptoms: Dysarthria. Dysphagia. Nasal speech. Difficulty chewing.
Limb Weakness: Proximal muscles affected more than distal. Arms often affected before legs
Respiratory Involvement: Respiratory muscle weakness. Myasthenic crisis
Examination
Findings: Fatigability on repeated movements. Ptosis increases with sustained upward gaze. Normal sensation. Normal reflexes
Diagnosis
- Serology: Anti-AChR antibodies. Anti-MuSK antibodies. Electrophysiology
- Repetitive Nerve Stimulation: Decremental response
- Single-Fiber EMG: Most sensitive test. Increased jitter
- Imaging
- CT/MRI chest: Detect thymoma
Treatment
Symptomatic: Pyridostigmine (AChE inhibitor)
Immunotherapy: Corticosteroids. Azathioprine. Mycophenolate
Rapid Treatment: Plasmapheresis. IVIG
Surgical: Thymectomy (especially thymoma)
Myasthenic Crisis
Definition: Life-threatening respiratory weakness requiring urgent treatment.
Management: ICU monitoring. Ventilatory support. IVIG or plasmapheresis